HAYWARD, Calif., Apr 06, 2010 (BUSINESS WIRE) --Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that its
first quarter 2010 financial results will be released before the market
opens on Tuesday, May 4, 2010 and will be available on Impax's Web site
at www.impaxlabs.com.
The Company will host a conference call and live webcast with financial
analysts at 11:00 a.m., Eastern Time.
The live webcast will be accessible through the Investor Relations
section of the company's Web site, www.impaxlabs.com.
To access the call through a conference line, dial (877) 356-3814 (in
the U.S.) and (706) 758-0033 (international callers) beginning at least
10 minutes prior to the scheduled start of the call.
A replay of the conference call will be available for seven days shortly
after the call. To access the replay, dial (800) 642-1687 (in the U.S.)
and (706) 645-9291 (international callers). The access conference code
is 67229487.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. is a technology based specialty pharmaceutical
company applying its formulation expertise and drug delivery technology
to the development of controlled-release and specialty generics in
addition to the development of branded products. Impax markets its
generic products through its Global Pharmaceuticals division and markets
its branded products through the Impax Pharmaceuticals division.
Additionally, where strategically appropriate, Impax has developed
marketing partnerships to fully leverage its technology platform. Impax
Laboratories is headquartered in Hayward, California, and has a full
range of capabilities in its Hayward, Philadelphia and Taiwan
facilities. For more information, please visit the Company's Web site
at: www.impaxlabs.com.
SOURCE: Impax Laboratories, Inc.
Impax Laboratories, Inc.
Mark Donohue
Sr. Director, Investor Relations and Corporate Communications
(215) 933-3526
www.impaxlabs.com